We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
-12.02%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.78B
AUM Growth
-$210M
Cap. Flow
+$95.4M
Cap. Flow %
5.37%
Top 10 Hldgs %
53.02%
Holding
70
New
17
Increased
15
Reduced
10
Closed
25

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$137M
2
SRCL
Stericycle Inc
SRCL
+$108M
3
ABT icon
Abbott
ABT
+$95.2M
4
PFE icon
Pfizer
PFE
+$90.4M
5
LLY icon
Eli Lilly
LLY
+$84.4M

Top Sells

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$115M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$111M
3
HCA icon
HCA Healthcare
HCA
+$68.6M
4
CI icon
Cigna
CI
+$52.6M
5
DHR icon
Danaher
DHR
+$51.4M

Sector Composition

Rank Sector Weight
1 Healthcare 61.33%
2 Industrials 6.08%
3 Financials 4%
4 Real Estate 0.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALR
26
DELISTED
Alere Inc
ALR
$19.3M 1.08%
400,000
-325,000
-45% -$16.8M
SGNT
27
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$19.2M 1.08%
1,250,000
+337,619
+37% +$7.3M
ABCO
28
DELISTED
Advisory Board Co
ABCO
$15.4M 0.87%
338,252
-336,748
-50% -$17.5M
RLYP
29
DELISTED
RELYPSA INC COM
RLYP
$15.3M 0.86%
829,041
+6,149
+0.7% +$169K
ANAC
30
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$14.7M 0.83%
+125,000
New +$16.3M
ABUS icon
31
Arbutus Biopharma
ABUS
$857M
$13.1M 0.74%
2,150,000
+425,000
+25% +$3.77M
A icon
32
Agilent Technologies
A
$39.1B
$11.2M 0.63%
+325,500
New +$12.3M
CEMP
33
DELISTED
Cempra, Inc.
CEMP
$9.74M 0.55%
+350,000
New +$13M
SPNE
34
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$8.1M 0.46%
+500,000
New +$8.16M
NBIX icon
35
Neurocrine Biosciences
NBIX
$16.8B
$5.97M 0.34%
+150,000
New +$7.25M
WELL icon
36
Welltower
WELL
$169B
$4.93M 0.28%
+72,750
New +$4.86M
VTR icon
37
Ventas
VTR
$48B
$4.88M 0.27%
+87,020
New +$5.71M
HSTO
38
DELISTED
Histogen Inc. Common Stock
HSTO
$4.49M 0.25%
5,043
-55
-1% -$50.1K
CYAD
39
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$3.65M 0.21%
87,181
+22,181
+34% +$1.14M
ASMB icon
40
Assembly Biosciences
ASMB
$498M
$3.05M 0.17%
26,552
-15,562
-37% -$2.74M
NTRA icon
41
Natera
NTRA
$38.3B
$2.77M 0.16%
+255,000
New +$4.32M
DXCM icon
42
DexCom
DXCM
$31.5B
$2.15M 0.12%
100,000
-970,000
-91% -$21.6M
TNDM icon
43
Tandem Diabetes Care
TNDM
$1.34B
$1.99M 0.11%
22,580
+2,620
+13% +$305K
CPRX
44
DELISTED
Catalyst Pharmaceutical
CPRX
$1.16M 0.07%
385,500
– –
OREX
45
DELISTED
Orexigen Therapeutics, Inc.
OREX
$897K 0.05%
42,500
– –
BIIB icon
46
Biogen
BIIB
$30B
– –
-32,140
Closed -$13M
BMRN icon
47
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-162,500
Closed -$22.2M
CI icon
48
Cigna
CI
$73.7B
– –
-325,000
Closed -$52.6M
DHR icon
49
Danaher
DHR
$137B
– –
-892,699
Closed -$51.4M
EW icon
50
CALL
Edwards Lifesciences
EW
$49.6B
– –
-1,545,600
Closed -$36.7M
1
2
3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q3 2015 Portfolio in Review

As of Q3 2015, HealthCor Management held 70 positions worth $1.78B, down 11% from $1.99B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

HealthCor Management deployed $95.4M of net new capital in Q3 2015, opening 17 new positions and adding to 15 existing holdings. Its largest new stake was Stericycle Inc: 775,000 shares worth $108M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 60% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was HCA Healthcare, an estimated $68.6M trimmed.

  • HealthCor Management's largest Q3 2015 buy was Stericycle Inc: 775,000 shares worth $108M.
  • HealthCor Management added most to Allergan plc in Q3 2015, an estimated $137M increase.
  • HealthCor Management's biggest Q3 2015 reduction was HCA Healthcare, cutting an estimated $68.6M.
  • HealthCor Management fully exited MALLINCKRODT PUBLIC LIMITED COMPANY in Q3 2015, selling an estimated $115M.
  • HealthCor Management's ten largest holdings make up 53% of its $1.78B portfolio in Q3 2015.
  • HealthCor Management opened 17 new positions and closed 25 in Q3 2015.
  • HealthCor Management's portfolio value fell 11% quarter-over-quarter to $1.78B.

Based on HealthCor Management's 13F filing for Q3 2015, filed 16 Nov 2015.